ES2031904T3 - Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio. - Google Patents

Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio.

Info

Publication number
ES2031904T3
ES2031904T3 ES198787307943T ES87307943T ES2031904T3 ES 2031904 T3 ES2031904 T3 ES 2031904T3 ES 198787307943 T ES198787307943 T ES 198787307943T ES 87307943 T ES87307943 T ES 87307943T ES 2031904 T3 ES2031904 T3 ES 2031904T3
Authority
ES
Spain
Prior art keywords
aluminum hydroxide
pharmaceutical composition
ibuprophen
procedure
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787307943T
Other languages
English (en)
Inventor
Mahendra Govind Pankhania
Colin John Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Application granted granted Critical
Publication of ES2031904T3 publication Critical patent/ES2031904T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA PARA ADMINISTRACION ORAL QUE COMPRENDE UNA MEZCLA DE IBUPROFEN O UNA DE SUS SALES FISIOLOGICAMENTE COMPATIBLES E HIDROXIDO DE ALUMINIO, SIENDO LA CANTIDAD DE ESTE SUFICIENTE PARA ENMASCARAR EL SABOR DEL IBUPROFEN, O DE SU SAL, QUE ES NOTABLE EN AUSENCIA DEL HIDROXIDO DE ALUMINIO. LA RELACION DE HIDROXIDO DE ALUMINIO (EXPRESADO COMO EQUIVALENTE DE OXIDO DE ALUMINIO) A IBUPROFEN PUEDE ESTAR EN EL INTERVALO DE 1:50 A 5;1 PARTES EN PESO.
ES198787307943T 1986-10-01 1987-09-09 Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio. Expired - Lifetime ES2031904T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868623557A GB8623557D0 (en) 1986-10-01 1986-10-01 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2031904T3 true ES2031904T3 (es) 1993-01-01

Family

ID=10605072

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787307943T Expired - Lifetime ES2031904T3 (es) 1986-10-01 1987-09-09 Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio.

Country Status (16)

Country Link
US (1) US4831058A (es)
EP (1) EP0264187B1 (es)
JP (1) JPS63101321A (es)
KR (1) KR950009090B1 (es)
AT (1) ATE58471T1 (es)
AU (1) AU594607B2 (es)
CA (1) CA1306686C (es)
DE (1) DE3766343D1 (es)
DK (1) DK503687A (es)
ES (1) ES2031904T3 (es)
GB (1) GB8623557D0 (es)
GR (1) GR3001284T3 (es)
IE (1) IE61062B1 (es)
NZ (1) NZ221962A (es)
PT (1) PT85829B (es)
ZA (1) ZA876731B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
DE3938227C1 (en) * 1989-11-17 1991-05-02 Dolorgiet Gmbh & Co Kg, 5205 St Augustin, De Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
ES2202302T3 (es) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
JP3168582B2 (ja) * 1993-12-10 2001-05-21 藤沢薬品工業株式会社 解熱鎮痛配合剤
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US6376481B2 (en) * 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
AU753476B2 (en) * 1998-11-25 2002-10-17 Cima Labs, Inc. Taste masking rapid release coating system
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
JP5519890B2 (ja) * 2001-02-28 2014-06-11 エスエス製薬株式会社 経口用イブプロフェン製剤
JP2004537566A (ja) * 2001-08-01 2004-12-16 ブリストル−マイヤーズ　スクイブ　カンパニー 味マスキング組成物
NZ534746A (en) * 2002-03-12 2006-06-30 Bristol Myers Squibb Co Palatable oral suspension and method
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EP2158913A1 (en) * 2008-08-25 2010-03-03 Ratiopharm GmbH Pharmaceutical composition comprising N-[3-chhloro-4-[(3-fluorophenyl)methoxy]phenyl]6-(5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine
JP5740896B2 (ja) * 2009-10-27 2015-07-01 ライオン株式会社 解熱鎮痛組成物
JP6140570B2 (ja) * 2013-08-13 2017-05-31 ライオン株式会社 イブプロフェン含有錠剤及びその製造方法
US10821073B1 (en) 2013-09-30 2020-11-03 Make Ideas, LLC Edible animal medicine container
US9498433B1 (en) * 2013-09-30 2016-11-22 Make Ideas, LLC Edible animal medicine container
JP6877923B2 (ja) * 2016-09-06 2021-05-26 ライオン株式会社 内服用半固形製剤及びその製造方法
US11503806B1 (en) 2018-06-12 2022-11-22 Make Ideas Llc Dog dental device with brushes extending through compressible outer shell
KR102946316B1 (ko) * 2018-11-16 2026-03-31 에스에스 세야쿠 가부시키 가이샤 이부프로펜 함유 경구용 제약 제제

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
DE2213704C3 (de) * 1971-03-22 1975-06-12 Teikoku Hormone Manufacturing Co. Ltd., Tokio 07.03.72 Japan 22767-72 Verfahren zur Herstellung von Aluminiumsalzen von Carboxylgruppen enthaltenden, pharmazeutisch wirksamen Verbindungen
GB1435892A (en) * 1972-07-04 1976-05-19 Beecham Group Ltd Aluminium complexes of guaiphenesin
GB1451541A (en) * 1974-02-16 1976-10-06 Lilly Co Eli Aluminum salts of substituted phenyl-alkanoic acids and pharma ceutical suspensions prepared therefrom core-sampling device for obtaining a core sample from a loose
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
IT1175941B (it) * 1984-02-16 1987-08-12 Stabil Bioterapico Farmachim Sali d'alluminio mono, bi e trisostituiti degli acidi aril-alcanoici e composizioni farmaceutiche che li contengono
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
AT385894B (de) * 1985-10-04 1988-05-25 Basem Dr Nashef Schlauchfoermige sonde
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation

Also Published As

Publication number Publication date
GR3001284T3 (en) 1992-08-26
IE872400L (en) 1989-03-08
IE61062B1 (en) 1994-09-21
KR880004807A (ko) 1988-06-27
NZ221962A (en) 1990-03-27
KR950009090B1 (ko) 1995-08-14
AU594607B2 (en) 1990-03-08
DK503687A (da) 1988-04-02
PT85829A (en) 1987-10-01
US4831058A (en) 1989-05-16
EP0264187A1 (en) 1988-04-20
PT85829B (pt) 1990-07-31
ZA876731B (en) 1988-03-14
EP0264187B1 (en) 1990-11-22
ATE58471T1 (de) 1990-12-15
DK503687D0 (da) 1987-09-25
CA1306686C (en) 1992-08-25
AU7921887A (en) 1988-04-14
JPS63101321A (ja) 1988-05-06
DE3766343D1 (de) 1991-01-03
GB8623557D0 (en) 1986-11-05

Similar Documents

Publication Publication Date Title
ES2031904T3 (es) Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio.
LV5801A4 (lv) Omeprazola pievienotas bazes sali
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
ES2074513T3 (es) Utilizacion de un antagonista opiaceo para la preparacion de una composicion farmaceutica para administracion transdermica y dispositivo para el suministro percutaneo.
ES2026944T3 (es) Procedimiento para preparar un sistema de suministro de edulcorante contenido acetato de polivinilo.
MX174336B (es) Composiciones que contienen l-tartrato de l-carnitina y procedimiento para su preparacion
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2061858T3 (es) Derivados sustituidos en posicion 7 del acido 3,5-dihidroxihept-6-inoico, procedimiento para su preparacion, su empleo como medicamentos, asi como productos intermedios.
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
ES2046493T3 (es) Procedimiento de preparacion de productos de confiteria duros que contienen principalmente xilitol.
ES2132101T3 (es) Procedimiento para la preparacion de un medicamento destinado a la administracion por via oral o topica en el tratamiento de leishmaniasis.
ES2029254T3 (es) Procedimiento para la preparacion de una sal de diclofenac con una base organica ciclica.
ES2052761T3 (es) Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
ES2021904A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un acido piperacinacarboxilico.
AR008371A1 (es) Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ
ES2061550T3 (es) Vinilcefalosporinas substituidas, procedimiento para su preparacion y su uso como medicamento.
MX174093B (es) 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA
ES436179A1 (es) Procedimiento para intensificar la eficacia de medicamentos que in vivo o in vitro demuestren una afinidad de enlace a proteinas de la sangre.
GB1110397A (en) Ephedrine composition
ES2080107T3 (es) Medicamento que contiene una combinacion de azt y amantadina para el tratamiento del sida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 264187

Country of ref document: ES